| DB ID | MyCo_1135 |
| Title | High prevalence of pneumocystis pneumonia in interstitial lung disease: a retrospective study |
| Year | 2024 |
| PMID | 38147199 |
| Fungal Diseases involved | Pneumocystis pneumonia |
| Associated Medical Condition | Interstitial lung disease |
| Genus | Pneumocystis |
| Species | jirovecii |
| Organism | Pneumocystis jirovecii |
| Ethical Statement | This study was approved by the Ethics Committee of Nanjin University Medical School Affiliated Drum Tower Hospi-tal according to the policy (protocol number 2022- 067-02, March 28, 2022). |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Blood |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | BDG |
| Biomarker Full Name | 1-3-beta-D-Glucan |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | China |
| Cohort | A total of 92 hospitalized patients with ILD who underwent mNGS were screened |
| Cohort No. | 92 |
| Age Group | None |
| P Value | None |
| Sensitivity | 0.774 |
| Specificity | 0.825 |
| Positive Predictive Value | 0.706 |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Assay |
| Analysis Method | BDG assay |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | Immunological assay, BDG Assay |
| Up Regulation Down Regulation | Positive |
| Sequence Data | None |
| External Link | None |
